2. Academic Validation
  3. Pharmacological interventions on GSK3β phosphorylation-mediated tau aggregation by modulating phase separation of tau proline-rich domain

Pharmacological interventions on GSK3β phosphorylation-mediated tau aggregation by modulating phase separation of tau proline-rich domain

  • Biomed Pharmacother. 2025 Aug:189:118290. doi: 10.1016/j.biopha.2025.118290.
Shan Sun 1,  Siqian Chen 1,  Junqiu He 2,  Bojun Yang 3,  Yingping Zhang 3,  Ningning Li 3,  Hongfeng Wang 4,  Kin Yip Tam 5,  Zheng Ying 6
Affiliations

Affiliations

  • 1 Faculty of Health Sciences, University of Macau, Taipa, Macau, China; Jiangsu Key Laboratory of Drug Discovery and Translational Research for Brain Diseases, College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu 215123, China.
  • 2 Faculty of Health Sciences, University of Macau, Taipa, Macau, China.
  • 3 Jiangsu Key Laboratory of Drug Discovery and Translational Research for Brain Diseases, College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu 215123, China.
  • 4 Jiangsu Key Laboratory of Drug Discovery and Translational Research for Brain Diseases, College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu 215123, China; MOE Key Laboratory of Geriatric Diseases and Immunology, College of Pharmaceutical Sciences, Suzhou Medical College of Soochow University, Suzhou, Jiangsu 215123, China. Electronic address: wanghongfeng@suda.edu.cn.
  • 5 Faculty of Health Sciences, University of Macau, Taipa, Macau, China. Electronic address: kintam@um.edu.mo.
  • 6 Jiangsu Key Laboratory of Drug Discovery and Translational Research for Brain Diseases, College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu 215123, China; MOE Key Laboratory of Geriatric Diseases and Immunology, College of Pharmaceutical Sciences, Suzhou Medical College of Soochow University, Suzhou, Jiangsu 215123, China; Jiangsu Province Engineering Research Center of Precision Diagnostics and Therapeutics Development, Soochow University, Suzhou, Jiangsu 215123, China. Electronic address: zheng.ying@suda.edu.cn.
PMID: 40580878 DOI: 10.1016/j.biopha.2025.118290
Abstract

Tau pathological aggregation in neurofibrillary tangles is a hallmark of several neurodegenerative diseases, including Alzheimer's disease. Phase separation is a thermodynamic process that plays an important role in biomolecular membrane-less condensate formation, while abnormal phase separation of tau leads to pathological aggregate formation. However, the detailed molecular mechanism underlying tau condensation remains not fully understood. Moreover, whether condensation-based pharmacological intervention will be helpful for the treatment of tau-associated neurodegenerative diseases remains elusive. Here, we used an optogenetic tool (optoDroplets) in combination with Cell Biology and pharmacology to explore the contribution of different domains for tau condensation in cells, and we found that proline-rich domain (PRD) phosphorylation, which is mainly regulated by glycogen synthase kinase 3 β (GSK3β), plays important roles for tau condensation. Moreover, phosphorylation of tau PRD regulates its mis-localization on nuclear speckle. Interestingly and importantly, we found that pharmacological inhibition of GSK3β can impede abnormal tau condensation to slow down the tau-associated pathological process.

Keywords

Alzheimer’s disease; Condensation; GSK3β; Phase separation; Proline-rich domain; Tau.

Figures
Products